Erratum for Ruthenium (II) Complexes Based on Phenanthroline-Tetrazole as Possible Anticancer Agents [Iran J Pharm Res. 2023;22(1): e136738]
Saeid Abaspour, Behzad Soltani, Hamed Hamishehkar, Moayad Hossaini Sadr
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSynthesis of Tetrazole Derivatives · Chemotherapy-induced organ toxicity mitigation · Nanomaterials for catalytic reactions
We would like to correct an error in the published article regarding the affiliation of the corresponding author (1). This mistake originated from the authors during the manuscript submission process. The correct affiliation of the corresponding author is as follows:
Chemistry Department, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran.
We sincerely apologize for this oversight and any confusion it may have caused. We take full responsibility for the error and appreciate your understanding.
Sincerely Yours,
Dr. Elham Rezaee
School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Editor-in-Chief of IJ Pharmaceutical Research
The reference list from the paper itself. Each links out to its DOI / PubMed record.